Company Filing History:
Years Active: 2018-2023
Title: Innovations by Timothy James Wooster
Introduction
Timothy James Wooster is an accomplished inventor based in Epalinges, Switzerland. He has made significant contributions to the field of allergy treatment, particularly concerning human allergies to cats. With a total of four patents to his name, Wooster's work focuses on innovative compositions and methods that aim to alleviate allergy symptoms.
Latest Patents
Wooster's latest patents include compositions and methods for reducing at least one symptom of human allergy to cats. These innovations enhance the effectiveness of a molecule that specifically binds to Feline domesticus allergen number 1 (Fel D1). The effectiveness is improved by prolonging the time the immunoglobulin remains in the mouth of a cat, to which the anti-Fel D1 molecule is administered through pet food. The compositions utilize a powder that is a dried hydrogel encapsulating the anti-Fel D1 molecule. This hydrogel is based on gelatin, collagen peptides, or a combination of both, along with carrageenan. The methods for creating this powder ensure high encapsulation efficacy, sustained release of the anti-Fel D1 molecule in the cat's mouth, and oral adhesion of the molecule.
Career Highlights
Throughout his career, Wooster has worked with notable companies, including Société des Produits Nestlé S.A. and Societe Des Produits Nestle S.A. His experience in these organizations has contributed to his expertise in developing innovative solutions for allergy treatment.
Collaborations
Some of Wooster's coworkers include Ebenezer Satyaraj and Eddy Gombas. Their collaboration has likely played a role in advancing the research and development of allergy-related innovations.
Conclusion
Timothy James Wooster's contributions to allergy treatment through his innovative patents demonstrate his commitment to improving the quality of life for individuals affected by cat allergies. His work continues to pave the way for advancements in this important field.